P. Scott-Stevens

发表

Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

Aditya R. Thawani, I. E. Smith, Carol A. Capriotti, 2020, Communications Biology.

An evaluation of a low-density DNA microarray using cytochrome P450 inducers.

F. de Longueville, V. Bertholet, G. Meneses‐Lorente, 2003, Chemical research in toxicology.

Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans

J. Baron, T. Fryer, D. Wong, 2010, Journal of Pharmacology and Experimental Therapeutics.

Comparison of Lorazepam [7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] Occupancy of Rat Brain γ-Aminobutyric AcidA Receptors Measured Using in Vivo [3H]Flumazenil (8-Fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic Acid Ethyl Ester)

J. Baron, T. Fryer, J. Atack, 2007, Journal of Pharmacology and Experimental Therapeutics.

First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer’s Disease: A Randomized, Placebo-Controlled Study

T. Fladby, H. Zetterberg, A. Wallin, 2015, PloS one.

Optimization of a Series of RIPK2 PROTACs.

Aditya R. Thawani, I. E. Smith, R. Nagilla, 2021, Journal of medicinal chemistry.

Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L‐838417

P. Worboys, J. Atack, P. Scott-Stevens, 2005, Biopharmaceutics & drug disposition.

Comparison of Lorazepam [7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one] Occupancy of Rat Brain (cid:1) -Aminobutyric Acid A Receptors Measured Using in Vivo [ 3 H]Flumazenil (8-Fluoro 5,6-dihydro-5-methyl-6-oxo-4 H -imidazo[1,5- a ][1,4]benzodiazepine-3-carboxylic Ac

J. Baron, T. Fryer, J. Atack, 2007 .

Comparison of Lorazepam Occupancy of Rat Brain GABAA Receptors Measured Using In Vivo [H]Flumazenil Binding and [C]Flumazenil microPET

J. Baron, T. Fryer, J. Atack, 2006 .

Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands

R. Mckernan, A. Pike, J. Atack, 2007, Biopharmaceutics & drug disposition.

Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist

D. O'connor, M. Braun, A. Macleod, 2006, Xenobiotica; the fate of foreign compounds in biological systems.